Radiopharmaceuticals are medications and treatments created using radioactive and nuclear isotopes. Radiopharmaceuticals can be designed to target certain organs or tissues in the body, which can improve the accuracy of diagnosis and treatment. These pharmaceuticals can allow for more precise radiation therapy with fewer side effects. Typically, radiopharmaceuticals are used to treat various medical conditions, including cancer, heart disease, and neurological disorders.
Radiopharmaceuticals can be also used for diagnostic services, where specialized imaging equipment, such as gamma cameras or positron emission tomography (PET) scanners are used to obtain detailed information about the structures and functions of organs and tissues.
Radiopharmaceuticals have gained traction recently, as they provide a non-invasive method of diagnosing and monitoring diseases, and, more recently, standards in handling and refining isotopes have seen improvements. More recent studies have also shown that radiopharmaceuticals typically have a short half-life, indicating a quick decay and thus not remaining in the body for an extended period of time, reducing the risk of long-term side effects.
Note: Additional sections (such as market sizing, detailed overview, and incumbents) can be provided on request.